Neuren Pharmaceuticals Limited (AU:NEU) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Neuren Pharmaceuticals Limited has announced a daily update on its ongoing on-market buy-back program, revealing that 37,029 ordinary shares were repurchased on the previous day, contributing to a total of 561,507 shares bought back to date. This strategic move is aimed at enhancing shareholder value by reducing the number of outstanding shares. Investors interested in Neuren’s financial activities may find this development noteworthy.
For further insights into AU:NEU stock, check out TipRanks’ Stock Analysis page.
